跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RASILEZ HCT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RASILEZ HCT
Authorized
STANDARD
RASILEZ HCT
Noden Pharma DAC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
18c04d411af9bc5a
Company
Noden Pharma DAC
Type
Standard
Approval Details
Approval Id
18c04d411af9bc5a
Drug Approval Canada Name
RASILEZ HCT
Product Name
RASILEZ HCT
Status
Cancelled Post Market
Status Date
2020-02-11
Original Market Date
2009-11-24
Din
02332736
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.20
Atc Original
C09XA52 ALISKIREN AND HYDROCHLOROTHIAZIDE
Atc Name
c 09 xa 52
Aig Number
0252648001
Company Name
Noden Pharma DAC
Company Address
D'Olier Chambers, 16a D'Olier Street, Dublin, Dublin, Ireland
Company Detail Path
/organization/noden-pharma-dac
Company Information
Pharmaceutical Company Name
Noden Pharma DAC
Country Name
Ireland
Website
http://www.nodenpharma.com
Active Ingredients
HYDROCHLOROTHIAZIDE
25 MG
ALISKIREN (ALISKIREN FUMARATE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
18c04d411af9bc5a
Type
Standard
Back to Health Canada Approvals